Table 1 Characteristics of study participants (n=51)
Age (median) | 51–83 (64) |
|---|---|
Gleason score, n (%) | |
5–6 | 20 (39) |
7 | 18 (36) |
8–10 | 13 (26) |
Clinical stage, n (%) | |
cT1 | 17 (33) |
cT2 | 28 (57) |
cT3 | 5 (10) |
Metastasis, n (%) | |
Yes | 18 (35) |
No | 33 (65) |
Biochemical recurrence, n (%) | |
Yes | 24 (47) |
No | 27 (53) |
Cx26 expression tumour tissue, n (%) | |
Score <100 (low) | 40 (87) |
Score >100 (high) | 11 (22) |
Cx26 expression noncancerous tissue, n (%) | |
Score <100 (low) | 26 (51) |
Score >100 (high) | 25 (49) |
